Literature DB >> 9714754

Cloning and characterization of human MCM7 promoter.

S Suzuki1, A Adachi, A Hiraiwa, M Ohashi, M Ishibashi, T Kiyono.   

Abstract

MCM7 is a member of the MCM protein family which has been implicated in the regulatory machinery allowing DNA to replicate only once during S phase. In quiescent cells, human MCM7 (hMCM7) mRNA is almost undetectable. Stimulation of cells to enter the cell cycle results in induction of hMCM7 expression. Here, we report cloning and characterization of the hMCM7 promoter. We isolated and sequenced a 0.5 kb genomic fragment that contains putative transcription factor binding sites including three E2F sites, three GC boxes and an E box. Several transcription start sites, which were used upon growth stimulation, were identified. The minimal promoter region required for transcription of a luciferase reporter gene was delineated, and it contained an E box and one E2F site, which were important for promoter activity. Interestingly, the cloned sequence appears to act as a promoter for mu-adaptin-related protein 2 (mu-ARP2) gene in the opposite orientation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714754     DOI: 10.1016/s0378-1119(98)00323-0

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  22 in total

1.  Reducing MCM levels in human primary T cells during the G(0)-->G(1) transition causes genomic instability during the first cell cycle.

Authors:  S J Orr; T Gaymes; D Ladon; C Chronis; B Czepulkowski; R Wang; G J Mufti; E M Marcotte; N S B Thomas
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

2.  Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions.

Authors:  Jianyin Long; Yin Wang; Wenjian Wang; Benny H J Chang; Farhad R Danesh
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

3.  Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary.

Authors:  Takayo Ota; Amy C Clayton; Douglas M Minot; Viji Shridhar; Lynn C Hartmann; C Blake Gilks; Jeremy R Chien
Journal:  Mod Pathol       Date:  2010-11-12       Impact factor: 7.842

4.  Regulation of p53-targeting microRNAs by polycyclic aromatic hydrocarbons: Implications in the etiology of multiple myeloma.

Authors:  Michael W Gordon; Fang Yan; Xiaoming Zhong; Pranab Behari Mazumder; Zijun Y Xu-Monette; Dehui Zou; Ken H Young; Kenneth S Ramos; Yong Li
Journal:  Mol Carcinog       Date:  2014-05-06       Impact factor: 4.784

5.  Tumorigenic activity of merkel cell polyomavirus T antigens expressed in the stratified epithelium of mice.

Authors:  Megan E Spurgeon; Jingwei Cheng; Roderick T Bronson; Paul F Lambert; James A DeCaprio
Journal:  Cancer Res       Date:  2015-01-16       Impact factor: 12.701

6.  The tumor suppressor protein HBP1 is a novel c-myc-binding protein that negatively regulates c-myc transcriptional activity.

Authors:  Julienne R Escamilla-Powers; Colin J Daniel; Amy Farrell; Karyn Taylor; Xiaoli Zhang; Sarah Byers; Rosalie Sears
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

7.  Regulation of miR106b cluster through the RB pathway: mechanism and functional targets.

Authors:  Chellappagounder Thangavel; Ettickan Boopathi; Adam Ertel; Meng Lim; Sankar Addya; Paolo Fortina; Agnieszka K Witkiewicz; Erik S Knudsen
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

8.  Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation.

Authors:  Deepa Sampath; George A Calin; Vinay K Puduvalli; Gopal Gopisetty; Cristian Taccioli; Chang-Gong Liu; Brett Ewald; Chaomei Liu; Michael J Keating; William Plunkett
Journal:  Blood       Date:  2008-12-18       Impact factor: 22.113

9.  Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer.

Authors:  Susan McCarthy; Andrea Caporali; Steve Enkemann; Maurizio Scaltriti; Steve Eschrich; Pierpaola Davalli; Arnaldo Corti; Alice Lee; Jimmy Sung; Timothy J Yeatman; Saverio Bettuzzi
Journal:  Mol Oncol       Date:  2007-09       Impact factor: 6.603

10.  Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene.

Authors:  Sean F Jabbar; Linda Abrams; Adam Glick; Paul F Lambert
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.